Key facts
- Notable investors include Even One Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bulsara Bioworks
- ·The full record, as it builds
Funding rounds
No funding rounds for Bulsara Bioworks are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bulsara Bioworks
Developer of precision-activating cancer therapeutics designed to restore tumor suppressor function and improve outcomes for oncology patients. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Website
- bulsarabio.com/
- Ownership
- Privately Held (backing)
Bulsara Bioworks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bulsara Bioworks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bulsara Bioworks in its N-PORT filings yet. We sweep new filings monthly.